-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Acute basilar artery occlusion (BAO) is a rare but catastrophic condition that accounts for 1% of all ischemic strokes and 5% of large vessel occlusion (LVO) strokes
.
Despite recent progress in the treatment of acute stroke, up to 68% of patients with acute BAO die or remain severely disabled
Stroke vessels Although recent progress has been made in the treatment of acute strokes, up to 68% of patients with acute BAO die or remain severely disabled
It has been confirmed that early recanalization of occluded arteries in acute stroke is associated with a good functional prognosis
In May 2020, Qingwu Yang from Xinqiao Hospital, China, etc.
The BASILAR registration is a nationwide prospective non-randomized study conducted in China.
From January 2014 to May 2019, patients with acute basilar artery occlusion who received endovascular treatment or conventional treatment were continuously recruited
.
Recently, Professor Yang Qingwu from China's Third Military Medical University reported in the Stroke magazine the clinical follow-up results of these patients one year later
The main result of the trial is the modified Rankin scale one year later, using sequential logistic regression analysis to adjust the pre-specified prognostic factors to assess the prevalence
.
Secondary results included the result group (0-1, 0-2, or 0-3) based on the modified Rankin scale and all-cause death after one year
Of the 829 patients initially registered with BASILAR, one-year data were available for 785 patients (94.
7%)
.
In general, the distribution of the results of the revised Rankin Scale suggests that endovascular treatment, rather than traditional treatment, is beneficial for patients with basilar artery occlusion to obtain a better prognosis (OR=4.
In general, the distribution of the results of the revised Rankin Scale suggests that endovascular treatment, rather than traditional treatment, is beneficial for patients with basilar artery occlusion to obtain a better prognosis (OR=4.
Diagram of the main outcomes of the BASILAR trial
It can be seen that the beneficial effect of endovascular treatment on the functional outcome of patients with acute basilar artery occlusion after one year is similar to the 90-day report in the original study
.
.
It can be seen that the beneficial effect of endovascular treatment on the functional outcome of patients with acute basilar artery occlusion after one year is similar to the 90-day report in the original study
references:
One-Year Outcome After Endovascular Treatment for Acute Basilar Artery Occlusion.
One-Year Outcome After Endovascular Treatment for Acute Basilar Artery Occlusion.
Https://doi.
org/10.
1161/STROKEAHA.
120.
033658.
Leave a message here